Drugs / KHK4323
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03846466 | Feb → Dec 2019 | atopic eczema | Kyowa Kirin, Inc. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KHK4323 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03846466 ↗ |
| Route | Intravenous | “IV / Single administration” NCT03846466 ↗ |